AdvaMed® Response to Senate HELP Committee Regarding Reauthorization of Pandemic All-Hazards Preparedness Act

On March 29, AdvaMed® responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA). The submission includes a set of comprehensive recommendations to enhance national preparedness and response efforts for public health emergencies. We also outline policies that would bolster public health infrastructure, as well as coordination between the federal government and industry stakeholders.
Related Reading
Blog / Diagnostics / Government & Legislative Affairs / Health Access / Regulatory Affairs
Fixing Medicare’s Lab Payment System: Why the RESULTS Act Matters
November 18, 2026
Clinical laboratory tests are critical to how clinicians screen for disease, diagnose conditions, guide treatment, and monitor outcomes for patients with diabetes, cancer, heart disease, and more.
Blog / Government & Legislative Affairs / Health Access / Regulatory Affairs
Protecting Patient Access to Ostomy and Urological Supplies
November 18, 2026
For roughly one million Americans, ostomy and urological supplies are essential. Whether it is from a condition at birth, result of injury or trauma, or cancer- these products replace or support lost bowel and bladder function. Because they are so personal, each product must match a patient’s anatomy, skin, and daily needs. A poor fit or faulty product can easily lead to leakage, skin breakdown harming a person, and reduced quality of life. If these issues aren’t addressed-the problems compound leading to infection, and hospitalization.
Resource / Government & Legislative Affairs / Health Access / Regulatory Affairs
U.S. Evidence Snapshot: Medtech Saves Lives
November 17, 2026
U.S. life expectancy has reached its highest level in history. Age-adjusted death rates for the leading causes of death dropped from 2023 to 2024, according to preliminary CDC data.
Resource / Government & Legislative Affairs / Regulatory Affairs
Justin Klein Op-Ed: CMS Can Make RAPID a Win for Patients and American Medtech Innovation
November 5, 2026
In this op-ed published in Medtech Insight, Justin Klein, MD, JD, explains how the proposed RAPID coverage pathway could accelerate Medicare access to breakthrough medical technologies and why targeted refinements are essential to its success.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Tariffs
AdvaMed® Advancements: Q3 2026 Report
November 5, 2026
Explore AdvaMed’s Q3 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation, expanding patient access to medtech, and strengthening the industry to serve patients.
News / AdvaMed Advancements / Artificial Intelligence (AI) / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Global & Trade / Health Access / Investor Relations / Medical Imaging / Orthopedic / Regulatory Affairs / Tariffs / The MedTech Conference / Value-Based Collaborations
AdvaMed Concludes Record-Breaking MedTech Conference 2026
October 28, 2026
BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.
News / Business Development / Diagnostics / Health Access
Scott Garrett Named 2026 Recipient of AdvaMedDx® Lifetime of Leadership & Service Award
October 19, 2026
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.
News / Business Development / Diagnostics / Health Access
AdvaMed Names Vince Forlenza 2026 Lifetime Achievement Award Winner
October 16, 2026
WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.